194 related articles for article (PubMed ID: 25989345)
21. Synthesis and antifungal activity of new 1-halogenobenzyl-3-imidazolylmethylindole derivatives.
Na YM; Le Borgne M; Pagniez F; Le Baut G; Le Pape P
Eur J Med Chem; 2003 Jan; 38(1):75-87. PubMed ID: 12593918
[TBL] [Abstract][Full Text] [Related]
22. Antifungal agents. VIII. Synthesis and antifungal activities of bipyrryl analogues of bifonazole.
di Santo R; Massa S; Costi R; Simonetti G; Retico A; Apuzzo G; Troccoli F
Farmaco; 1994 Apr; 49(4):229-36. PubMed ID: 8049002
[TBL] [Abstract][Full Text] [Related]
23. In vitro comparison of the antifungal activities of R34,000, miconazole and amphotericin B.
Dixon DM; Wagner GE; Shadomy S; Shadomy HJ
Chemotherapy; 1978; 24(6):364-7. PubMed ID: 699677
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, antifungal and cytotoxic activities of 2-aryl-3-((piperidin-1-yl)ethyl)thiazolidinones.
Kunzler A; Neuenfeldt PD; das Neves AM; Pereira CM; Marques GH; Nascente PS; Fernandes MH; Hübner SO; Cunico W
Eur J Med Chem; 2013 Jun; 64():74-80. PubMed ID: 23644190
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
Krátký M; Bősze S; Baranyai Z; Szabó I; Stolaříková J; Paraskevopoulos G; Vinšová J
Bioorg Med Chem; 2015 Feb; 23(4):868-75. PubMed ID: 25593095
[TBL] [Abstract][Full Text] [Related]
27. Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
Marco F; Pfaller MA; Messer SA; Jones RN
Med Mycol; 1998 Dec; 36(6):433-6. PubMed ID: 10206756
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antimicrobial properties of 3-aryl-1-(1,1'-biphenyl-4-yl)-2-(1H-imidazol-1-yl)propanes as 'carba-analogues' of the N-arylmethyl-N-[(1,1'-biphenyl)-4-ylmethyl])-1H-imidazol-1-amines, a new class of antifungal agents.
Castellano S; Stefancich G; Chillotti A; Poni G
Farmaco; 2003 Aug; 58(8):563-8. PubMed ID: 12875886
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and the selective antifungal activity of 5,6,7,8-tetrahydroimidazo[1,2-a]pyridine derivatives.
Ozdemir A; Turan-Zitouni G; Asim Kaplancikli Z; Işcan G; Khan S; Demirci F
Eur J Med Chem; 2010 May; 45(5):2080-4. PubMed ID: 20106559
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of novel 2H-chromen-2-one derivatives bearing 1,2,3-triazole moiety as lead antimicrobials.
Kushwaha K; Kaushik N; Lata ; Jain SC
Bioorg Med Chem Lett; 2014 Apr; 24(7):1795-801. PubMed ID: 24594353
[TBL] [Abstract][Full Text] [Related]
31. Rational design of antimicrobial agents: antifungal activity of alk(en)yl dihydroxybenzoates and dihydroxyphenyl alkanoates.
Nihei K; Nihei A; Kubo I
Bioorg Med Chem Lett; 2003 Nov; 13(22):3993-6. PubMed ID: 14592492
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antifungal activity evaluation of 3-hydroxyimidazo[1,2-a]pyridine and 3-hydroxyimidazo[1,2-a]pyrimidine derivatives.
Rival Y; Taudou A; Ecalle R
Farmaco; 1993 Jun; 48(6):857-69. PubMed ID: 8373508
[No Abstract] [Full Text] [Related]
33. Studies on antifungal agents. 23. Novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)- 2-alkylisoxazolidine derivatives.
Mullen GB; DeCory TR; Mitchell JT; Allen SD; Kinsolving CR; Georgiev VS
J Med Chem; 1988 Oct; 31(10):2008-14. PubMed ID: 3172137
[TBL] [Abstract][Full Text] [Related]
34. Antifungal agents. 10. Synthesis and antifungal activities of aryl-(1H-imidazol-1-yl)-(isoquinolin-1-yl) methane derivatives.
Silvestri R; Pagnozzi E; Troccoli F; Stefancich G; Massa S; Apuzzo G; Perazzi ME; Artico M; Simonetti G
Farmaco; 1995 Apr; 50(4):227-38. PubMed ID: 7669167
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of substituted pyrimidines, pyrazole[3,4-d]pyrimidines and imidazo[4,5-d]pyrimidines and evaluation of their antifungal activity.
Ronsisvalle G; Pappalardo MS; Vittorio F; Pasquinucci L; Bousquet E; Oliveri S; Cammarata E
Farmaco; 1989 Apr; 44(4):383-90. PubMed ID: 2775419
[TBL] [Abstract][Full Text] [Related]
36. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Fera MT; La Camera E; De Sarro A
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and antifungal activity of some new imidazole and triazole derivatives.
Rezaei Z; Khabnadideh S; Zomorodian K; Pakshir K; Kashi G; Sanagoei N; Gholami S
Arch Pharm (Weinheim); 2011 Oct; 344(10):658-65. PubMed ID: 21984016
[TBL] [Abstract][Full Text] [Related]
38. 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
La Regina G; D'Auria FD; Tafi A; Piscitelli F; Olla S; Caporuscio F; Nencioni L; Cirilli R; La Torre F; De Melo NR; Kelly SL; Lamb DC; Artico M; Botta M; Palamara AT; Silvestri R
J Med Chem; 2008 Jul; 51(13):3841-55. PubMed ID: 18529046
[TBL] [Abstract][Full Text] [Related]
39.
D'agostino M; Tesse N; Lavergne RA; Le Pape P; Frippiat JP; Machouart M; Debourgogne A
J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34491156
[No Abstract] [Full Text] [Related]
40. Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
Voelter-Ratson K; Monod M; Unger L; Spiess BM; Pot SA
Vet Ophthalmol; 2014 Jul; 17 Suppl 1():31-6. PubMed ID: 23910390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
